World J Diabetes. 2016 Jun 25;7(12):252-9. doi: 10.4239/wjd.v7.i12.252.

Does parity worsen diabetes-related chronic complications in women with type 1 diabetes?.

World journal of diabetes

Marilia Brito Gomes, Carlos Antonio Negrato, Ana Almeida, Antonio Ponce de Leon

PMID: 27350848 PMCID: PMC4914833 DOI: 10.4239/wjd.v7.i12.252

Abstract

AIM: To determine the relationship between parity, glycemic control, cardiovascular risk factors and diabetes-related chronic complications in women with type 1 diabetes.

METHODS: This was a multicenter cross-sectional study conducted between December 2008 and December 2010 in 28 public clinics in 20 cities from the 4 Brazilian geographic regions. Data were obtained from 1532 female patients, 59.2% Caucasians, and aged 25.2 ± 10.6 years. Diabetes duration was of 11.5 ± 8.2 years. Patient's information was obtained through a questionnaire and a chart review. Parity was stratified in five groups: Group 0 (nulliparous), group 1 (1 pregnancy), group 2 (2 pregnancies), group 3 (3 pregnancies), group 4 (≥ 4 pregnancies). Test for trend and multivariate random intercept logistic and linear regression models were used to evaluate the effect of parity upon glycemic control, cardiovascular risk factors and diabetes-related complications.

RESULTS: Parity was not related with glycemic control and nephropathy. Moreover, the effect of parity upon hypertension, retinopathy and macrovascular disease did not persist after adjustments for demographic and clinical variables in multivariate analysis. For retinopathy, the duration of diabetes and hypertension were the most important independent variables and for macrovascular disease, these variables were age and hypertension. Overweight or obesity was noted in a total of 538 patients (35.1%). A linear association was found between the frequency of overweight or obesity and parity (P = 0.004). Using a random intercept multivariate linear regression model with body mass index (BMI) as dependent variable a borderline effect for parity (P = 0.06) was noted after adjustment for clinical and demographic data. The observed variability of BMI was not attributable to differences between centers.

CONCLUSION: Our results suggest that parity has a borderline effect on body mass index but does not have an important effect upon hypertension and micro or macrovascular chronic complications. Future prospective evaluations must be conducted to clarify the relationship between parity, appearance or worsening of diabetes-related chronic complications.

Keywords: Cardiovascular risk factors; Diabetes-related chronic complications; Glycemic control; Parity; Type 1 diabetes

References

1. Clin Chem. 1972 Jun;18(6):499-502 - PubMed
2. Acta Obstet Gynecol Scand. 2002 Dec;81(12):1110-5 - PubMed
3. Am J Obstet Gynecol. 1988 Jul;159(1):56-66 - PubMed
4. Br J Ophthalmol. 1980 Jun;64(6):398-403 - PubMed
5. Diabetologia. 2010 May;53(5):809-20 - PubMed
6. Diabet Med. 2011 Oct;28(10):1188-93 - PubMed
7. J Physiol Pharmacol. 2011 Oct;62(5):567-73 - PubMed
8. Growth Horm IGF Res. 2011 Feb;21(1):25-30 - PubMed
9. Diabet Med. 2013 Sep;30(9):1087-93 - PubMed
10. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253 - PubMed
11. Acta Endocrinol Suppl (Copenh). 1986;277:122-4 - PubMed
12. Diabetes Care. 1995 Jul;18(7):950-4 - PubMed
13. Pediatr Diabetes. 2009 Aug;10(5):310-5 - PubMed
14. Diabetes Care. 2000 Aug;23(8):1084-91 - PubMed
15. Diabet Med. 1995 Jun;12(6):494-9 - PubMed
16. J Diabetes Complications. 1998 Mar-Apr;12(2):74-80 - PubMed
17. Diabetes Care. 1992 Nov;15(11):1509-16 - PubMed
18. Am J Obstet Gynecol. 1996 Apr;174(4):1180-9; discussion 1189-91 - PubMed
19. Acta Diabetol. 2013 Oct;50(5):781-7 - PubMed
20. BMJ Open. 2012 Feb 14;2(1):e000601 - PubMed
21. Diabet Med. 2010 Apr;27(4):431-5 - PubMed
22. Diabet Med. 1996 Feb;13(2):165-9 - PubMed
23. Br Med J (Clin Res Ed). 1985 Mar 16;290(6471):811-5 - PubMed
24. Clin Obstet Gynecol. 1991 Sep;34(3):516-25 - PubMed
25. Diabetes Res Clin Pract. 2012 Jul;97(1):63-70 - PubMed

Publication Types

• Journal Article